EPE205 When the only intervention left to optimise is retention: Comparing the 2021 and 2016 South African HIV Investment CasesE-posterNational financing analyses and financing mechanisms for HIV, hepatitis and STI programmes and services
EPE206 Sustainability of community-based social services for key populations in Russia: problems and prospects of national investment programsE-posterNational financing analyses and financing mechanisms for HIV, hepatitis and STI programmes and services
EPE207 An analysis of domestic funds on HIV/AIDS intervention from 2010- 2020 by the Nigerian GovernmentE-posterNational financing analyses and financing mechanisms for HIV, hepatitis and STI programmes and services
OAE0404 Estimated costs to address unmet financial needs for HIV pre-exposure prophylaxis, United States, 2018Oral abstract session with live Q&ANational financing analyses and financing mechanisms for HIV, hepatitis and STI programmes and services
PESUE21 Domestic public spending in low-and-middle-income countries 2006-2020: levels and trendsPoster exhibitionNational financing analyses and financing mechanisms for HIV, hepatitis and STI programmes and services
EPA034 Characterization of tissue-resident CD8 T-cells in the pulmonary mucosa of people living with HIV on long-term ARTE-posterMucosal immunity
EPA035 HIV clade C gp140-SIV-Gag/Nef protein vaccine adjuvanted with NE/AS01B enhanced antibody-mediated effector function and reduced viral loads in SHIV-infected macaquesE-posterMucosal immunity
EPA036 Interplay between the lung microbiome, pulmonary immunity and HIV reservoirs in people living with HIVE-posterMucosal immunity
EPLBA03 Transcriptome analysis to identify the changes in microRNA expression profile and their targeted pathways in the cervicovaginal mucosa of HIV-infected womenE-posterMucosal immunity
PESUA15 Depot-medroxyprogeterone acetate use alters immune modulation function of cortisol and thyroid hormonesPoster exhibitionMucosal immunity
861 - 870 of 2485 items